Td Asset Management Inc Axsome Therapeutics, Inc. Transaction History

Td Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$57.42 - $83.61 $918,720 - $1.34 Million	16,000 New	16,000 $1.27 Million
Q3 2021 Nov 09, 2021	SELL	$19.91 - $68.26 $699,159 - $2.4 Million	-35,116 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$50.63 - $73.5 $445,544 - $646,800	8,800 Added 33.44%	35,116 $1.71 Million
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $139,775 - $203,600	-2,500 Reduced 8.68%	26,316 $1.49 Million
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $212,192 - $276,864	3,200 Added 12.49%	28,816 $2.35 Million
Q2 2020 Aug 13, 2020	BUY	$49.87 - $98.69 $428,882 - $848,734	8,600 Added 50.54%	25,616 $2.11 Million
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $922,880 - $2.27 Million	-22,400 Reduced 56.83%	17,016 $1 Million
Q4 2019 Feb 11, 2020	BUY	$16.71 - $106.24 $53,739 - $341,667	3,216 Added 8.88%	39,416 $4.07 Million
Q3 2019 Nov 07, 2019	BUY	$20.24 - $29.16 $196,327 - $282,852	9,700 Added 36.6%	36,200 $733,000
Q2 2019 Aug 01, 2019	BUY	$13.46 - $25.75 $356,690 - $682,375	26,500 New	26,500 $682,000

327

38M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.56B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.